Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome

1 Dec 2017

Abstract excerpt

Myelodysplasia (MDS) /myeloproliferative neoplasm (MPN) overlap syndrome has been described since the 2001 WHO classification as disorders that have both proliferative and dysplastic changes simultaneously. Specific disorders include chronic myelomonocytic leukemia (CMML), juvenile myelomonocytic leukemia (JMML), BCR-ABL negative atypical chronic myeloid leukemia (aCML) and unclassifiable MDS/MPN (MPN/MDS-U)....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment
Share to Retinoids in leukemia and cellular processes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29225884
DOI: 10.1186/s40364-017-0113-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndromePMID 29225884Read ↗

Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.Semantic proximity Read ↗

SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.Semantic proximity Read ↗

Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review.Semantic proximity Read ↗

Surveying the landscape of MDS/MPN research: overlap among the overlap syndromes?Semantic proximity Read ↗

Myelodysplastic and myeloproliferative neoplasms: updates on the overlap syndromes.Semantic proximity Read ↗

Genetic Aspects of Myelodysplastic/Myeloproliferative NeoplasmsSemantic proximity Read ↗

Genomics of myelodysplastic/myeloproliferative neoplasm.Semantic proximity Read ↗

SETBP-1 mutations favor transformation to AML in PTPN-11 positive JMMLSemantic proximity Read ↗

Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.Semantic proximity Read ↗

Somatic SETBP1 mutations in myeloid malignancies.Semantic proximity Read ↗

Competitive evolved sub-clonal BCR::ABL1 and novel MSI2::PC fusion genes in myelodysplastic syndrome with isolated del(5q).Semantic proximity Read ↗

Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.